CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanism

European Journal of Immunology

Volumn 37, Issue 5, 2007, Pages 1266-1274

  Longhi, M Paula ^a,c   Williams, Anwen ^a   Wise, Matthew ^b   Morgan, B Paul ^a   Gallimore, Awen ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Inflammation; Lung; T cells; Virus

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; REGULATOR PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA VIRUS; INNATE IMMUNITY; LUNG INFILTRATE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; VIRUS STRAIN; WILD TYPE;

ANIMALS; ANTIGENS, CD59; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENT SYSTEM PROTEINS; INFLAMMATION; INFLUENZA A VIRUS; LUNG DISEASES; MICE; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 34250369554     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636755     Document Type: Article

References (40)

1. Wong, J., Saravolac, E., Clement, J. and Nagata, L., Development of a murine hypothermia model for study of respiratory tract influenza virus infection. Lab. Anim. Sci. 1999. 47: 143-147.
2. Conn, C. A., McClellan, J. L., Maassab, H. F., Smitka, C. W., Majde, J. A. and Kluger, M. J., Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1995. 268: R78-R84.
3. + T lymphocytes in experimental lung disease. J. Clin. Invest. 1998. 102: 1653-1661.
4. Taubenberger, J., Reid, A. and Fanning, T., The 1918 influenza virus: A killer comes into view. Virology 2000. 274: 241-245.
5. Wells, M., Albrecht, P. and Ennis, F., Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J. Immunol. 1981. 126: 1036-1041.
6. Singer, S. H., Noguchi, P. and Kirschstein, R. L., Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus. Infect. Immun. 1972. 5: 957-960.
7. Wiley, J. A., Cerwenka, A., Harkema, J. R., Dutton, R. W. and Harmsen, A. G., Production of interferon-γ by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am. J. Pathol. 2001. 158: 119-130.
8. Schmitz, N., Kurrer, M., Bachmann, M. F. and Kopf, M., Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection J. Viral. 2005. 79: 6441-6448.
9. Hussell, T., Permycook, A. and Openshaw, P., Inhibition of tumor necrosis factor reduces the severity of virus-specific lung inummopathology. Eur. J. Immunol. 2001. 31: 2566-2573.
10. + T cells. J. Immunol. 2004. 173: 721-725.
11. Yeldandi, A. and Colby, T., Pathologic features of lung biopsy specimens from influenza pneumonia cases. Hum. Pathol. 1994. 25: 47-53.
12. Mulligan, M., Watson, S., Fennie, C. and Ward, P., Protective effects of selectin chimeras in neutrophil-mediated lung injury. J. Immunol. 1993. 151: 6410-6417.
13. Doyle, N. A., Bhagwan, S. D., Meek, B. B., Kutkoski, G. J., Steeber, D. A., Tedder, T. F. and Doerschuk, C. M., Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice. J. Clin. Invest. 1997. 99: 526-533.
14. Kopf, M., Abel, B., Gallimore, A., Carroll, M. and Bachmann, M. F., Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Immunol. 2002. 8: 373-378.
15. + T cell responses. J. Immunol. 2004. 173: 2524-2529.
16. Czermak, B., Lentsch, A., Bless, N., Schmal, H., Friedl, H. and Ward, P., Role of complement in in vitro and in vivo lung inflammatory reactions. J. Leukoc. Biol. 1998. 64: 40-48.
17. Krug, N., Tschernig, T., Erpenbeck, V., Hohlfeld, J. and Kohl, J., Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am. J. Respir. Crit. Care Med. 2001. 164: 1841-1843.
18. Abe, M., Shibata, K., Akatsu, H., Shimizu, N., Sakata, N., Katsuragi, T. and Okada, H., Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J. Immunol. 2001. 167: 4651-4660.
19. Townsend, A. and Skehel, J., The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J. Exp. Med. 1984. 160: 552-563.
20. Harris, C. L., Hanna, S. M., Mizuno, M., Holt, D. S., Marchbank, K. J. and Morgan, B. P., Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: Tissue distribution and functional comparison. Immunology 2003. 109: 117-126.
21. Turnberg, D., Botto, M., Warren, J., Morgan, B. P., Walport, M. J. and Cook, H. T., CD59a deficiency exacerbates accelerated nephrotoxic nephritis in mice. J. Am. Soc. Nephrol. 2003. 14: 2271-2279.
22. Williams, A., Mizuno, M., Richards, P., Holt, D. and Morgan, B. P., Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid Arthritis. Arthritis Rheum. 2004. 50: 3035-3044.
23. + T cell activity in a complement-independent manner. J. Immunol. 2005. 175: 7098-7102.
24. + cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 1998. 188: 223-232.
25. Kobasa, D., Takada, A., Shinya, K., Hatta, M., Halfinann, P., Theriault, S., Suzuki, H. et al., Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004. 431: 703-707.
26. Tumpey, T. M., Garcia-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Pantin-Jackwood, M. J., Schultz-Cherry, S. et al., Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 2005. 79: 14933-14944.
27. Martin, U., Bock, D., Arseniev, L., Tornetta, M. A., Ames, R. S., Bautsch, W., Kohl, J. et al., The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J. Exp. Med. 1999. 186: 199-207.
28. Guo, R.-F. and Ward, P. A., Role of C5a in inflammatory responses. Ann. Rev. Immunol. 2005. 23: 821-852.
29. Kilgore, K., Shen, J., Miller, B., Ward, P. and Warren, J., Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 1995. 155: 1434-1441.
30. Kilgore, K., Schmid, E., Shanley, T., Flory, C., Maheswari, V., Tramontini, N., Cohen, H. et al., Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am. J. Pathol. 1999. 150: 2019-2031.
31. Snelgrove, R., Edwards, L., Rae, A. and Hussell, T., An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur. J. Immunol. 2006. 36: 1364-1373.
32. Liu, B., Mori, L, Hossain, M. J., Dong, L., Takeda, K. and Kimura, Y., Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol. 2004. 85: 423-428.
33. Karp, C., Grupe, A., Schadt, E., Ewart, S., Keane-Moore, M., Cuomo, P., Kohl, J. et al., Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 2001. 1: 221-226.
34. Baelder, R., Fuchs, B., Bautsch, W., Zwirner, J., Kohl, J., Hoymann, H. G., Glaab, T. et al., Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J. Immunol. 2005. 174: 783-789.
35. Longhi, M. P., Harris, C. L., Morgan, B. P. and Gallimore, A., Holding T cells in check - a new role for complement regulators? Trends Immunol. 2006. 27: 102-108.
36. + cell population in mice during Chlamydia pneumoniae infection. Infect. Immun. 1998. 66: 3290-3294.
37. Holt, D. S., Botto, M., Bygrave, A. E., Hanna, S. M., Walport, M. J. and Morgan, B. P., Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 2001. 98: 442-449.
38. Bachmann, M., Ecabert, B. and Kopf, M., Influenza virus: A novel method to assess viral and neutralizing antibody titers in vitro. J. Immunol. Methods 1999. 225: 105-111.
39. Beckstead, J., A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J. Histochem. Cytochem. 1994. 42: 1127-1134.
40. Jones, J., Laffafian, I. and Morgan, B., Purification of C8 and C9 from rat serum. Complement Inflamm. 1990. 7: 42-51.